There's no reason the U.S. can't pick up the pace to match the global clinical research front-runners without compromising ...

As venture capitalists pull back on their funding for life sciences, Big Pharma is flexing its considerable financial muscle to grab up smaller biotech companies, providing an injection of ...

Six so-called patient advocacy groups are working to advance corporate profits in the pharmaceutical industry by routinely ...

Big Pharma has invested big money in the organizations ... The same year, Washington’s top drug lobby — Pharmaceutical Research and Manufacturers of America, or PhRMA — donated $530,000 ...

There has been an increasing blurring of the lines between biotech and pharma. Many traditional big pharma companies now develop biologics. Some drugmakers refer to themselves as ...